{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:19:08Z","timestamp":1772507948378,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T00:00:00Z","timestamp":1300838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10557-011-6289-5","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T04:09:11Z","timestamp":1300766951000},"page":"171-182","source":"Crossref","is-referenced-by-count":121,"title":["Role of MicroRNAs in Cardiac Remodeling and Heart Failure"],"prefix":"10.1007","volume":"25","author":[{"given":"Veli K.","family":"Topkara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,23]]},"reference":[{"key":"6289_CR1","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","volume":"111","author":"DL Mann","year":"2005","unstructured":"Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111:2837\u201349.","journal-title":"Circulation"},{"key":"6289_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nm1569","volume":"13","author":"B Yang","year":"2007","unstructured":"Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13:486\u201391.","journal-title":"Nat Med"},{"key":"6289_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2007.03.030","volume":"129","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129:303\u201317.","journal-title":"Cell"},{"key":"6289_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","volume":"316","author":"E Rooij van","year":"2007","unstructured":"van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 2007;316:575\u20139.","journal-title":"Science"},{"key":"6289_CR5","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","volume":"103","author":"E Rooij van","year":"2006","unstructured":"van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6289_CR6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03817","volume":"436","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436:214\u201320.","journal-title":"Nature"},{"key":"6289_CR7","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.1074\/jbc.C700015200","volume":"282","author":"J Xiao","year":"2007","unstructured":"Xiao J, Luo X, Lin H, et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem. 2007;282:12363\u20137.","journal-title":"J Biol Chem"},{"key":"6289_CR8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","volume":"100","author":"D Sayed","year":"2007","unstructured":"Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res. 2007;100:416\u201324.","journal-title":"Circ Res"},{"key":"6289_CR9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2007.061170","volume":"170","author":"YH Cheng","year":"2007","unstructured":"Cheng YH, Ji RR, Yue JM, et al. MicroRNAs are aberrantly expressed in hypertrophic heart - Do they play a role in cardiac hypertrophy? Am J Pathol. 2007;170:1831\u201340.","journal-title":"Am J Pathol"},{"key":"6289_CR10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.yjmcc.2007.04.004","volume":"42","author":"M Tatsuguchi","year":"2007","unstructured":"Tatsuguchi M, Seok HY, Callis TE, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2007;42:1137\u201341.","journal-title":"J Mol Cell Cardiol"},{"key":"6289_CR11","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E Rooij van","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 2008;105:13027\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6289_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cvr\/cvp015","volume":"82","author":"S Roy","year":"2009","unstructured":"Roy S, Khanna S, Hussain SR, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009;82:21\u20139.","journal-title":"Cardiovasc Res"},{"key":"6289_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13:613\u201318.","journal-title":"Nat Med"},{"key":"6289_CR14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/CIRCULATIONAHA.108.813576","volume":"119","author":"SJ Matkovich","year":"2009","unstructured":"Matkovich SJ, Van Booven DJ, Youker KA, et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation. 2009;119:1263\u201371.","journal-title":"Circulation"},{"key":"6289_CR15","doi-asserted-by":"crossref","unstructured":"Naga Prasad SV, Duan ZH, Gupta MK, et al. A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009","DOI":"10.1074\/jbc.M109.036541"},{"key":"6289_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2008.04.014","volume":"45","author":"C Sucharov","year":"2008","unstructured":"Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008;45:185\u201392.","journal-title":"J Mol Cell Cardiol"},{"key":"6289_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","volume":"31","author":"S Ikeda","year":"2007","unstructured":"Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics. 2007;31:367\u201373.","journal-title":"Physiol Genomics"},{"key":"6289_CR18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart - A clue to fetal gene reprogramming in heart failure. Circulation. 2007;116:258\u201367.","journal-title":"Circulation"},{"key":"6289_CR19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1101\/gr.7179508","volume":"18","author":"RD Morin","year":"2008","unstructured":"Morin RD, O\u2019Connor MD, Griffith M, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18:610\u201321.","journal-title":"Genome Res"},{"key":"6289_CR20","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1261\/rna.1699809","volume":"15","author":"H Willenbrock","year":"2009","unstructured":"Willenbrock H, Salomon J, Sokilde R, et al. Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. RNA. 2009;15:2028\u201334.","journal-title":"RNA"},{"key":"6289_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.103.6.889","volume":"103","author":"R Dash","year":"2001","unstructured":"Dash R, Kadambi V, Schmidt AG, et al. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation. 2001;103:889\u201396.","journal-title":"Circulation"},{"key":"6289_CR22","first-page":"H1615","volume":"264","author":"Y Urabe","year":"1993","unstructured":"Urabe Y, Hamada Y, Spinale FG, et al. Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy. Am J Physiol. 1993;264:H1615\u201323.","journal-title":"Am J Physiol"},{"key":"6289_CR23","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1161\/01.CIR.96.11.3974","volume":"96","author":"IS Anand","year":"1997","unstructured":"Anand IS, Liu D, Chugh SS, et al. Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation. 1997;96:3974\u201384.","journal-title":"Circulation"},{"key":"6289_CR24","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/MCB.01222-08","volume":"29","author":"S Ikeda","year":"2009","unstructured":"Ikeda S, He A, Kong SW, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29:2193\u2013204.","journal-title":"Mol Cell Biol"},{"key":"6289_CR25","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.109.879429","volume":"120","author":"L Elia","year":"2009","unstructured":"Elia L, Contu R, Quintavalle M, et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation. 2009;120:2377\u201385.","journal-title":"Circulation"},{"key":"6289_CR26","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1101\/gad.1738708","volume":"22","author":"N Liu","year":"2008","unstructured":"Liu N, Bezprozvannaya S, Williams AH, et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008;22:3242\u201354.","journal-title":"Genes Dev"},{"key":"6289_CR27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich SJ, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res. 2010;106:166\u201375.","journal-title":"Circ Res"},{"key":"6289_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","volume":"13","author":"AM Krichevsky","year":"2009","unstructured":"Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13:39\u201353.","journal-title":"J Cell Mol Med"},{"key":"6289_CR29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980\u20134.","journal-title":"Nature"},{"key":"6289_CR30","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.0811371106","volume":"106","author":"Z Lin","year":"2009","unstructured":"Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA. 2009;106:12103\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6289_CR31","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1074\/jbc.M109.098004","volume":"285","author":"K Wang","year":"2010","unstructured":"Wang K, Long B, Zhou J, Li PF. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem. 2010;285:11903\u201312.","journal-title":"J Biol Chem"},{"key":"6289_CR32","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1172\/JCI119776","volume":"100","author":"K Nakao","year":"1997","unstructured":"Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997;100:2362\u201370.","journal-title":"J Clin Invest"},{"key":"6289_CR33","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest. 2009;119:2772\u201386.","journal-title":"J Clin Invest"},{"key":"6289_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","volume":"47","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol. 2009;47:5\u201314.","journal-title":"J Mol Cell Cardiol"},{"key":"6289_CR35","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1242\/jcs.010728","volume":"120","author":"C Xu","year":"2007","unstructured":"Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci. 2007;120:3045\u201352.","journal-title":"J Cell Sci"},{"key":"6289_CR36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","volume":"104","author":"S Rane","year":"2009","unstructured":"Rane S, He M, Sayed D, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009;104:879\u201386.","journal-title":"Circ Res"},{"key":"6289_CR37","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/CIRCULATIONAHA.108.814145","volume":"119","author":"XP Ren","year":"2009","unstructured":"Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia\/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009;119:2357\u201366.","journal-title":"Circulation"},{"key":"6289_CR38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCHEARTFAILURE.108.823070","volume":"2","author":"V Divakaran","year":"2009","unstructured":"Divakaran V, Adrogue J, Ishiyama M, et al. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail. 2009;2:633\u201342.","journal-title":"Circ Heart Fail"},{"key":"6289_CR39","doi-asserted-by":"crossref","unstructured":"Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104:170\u20138, p. 6","DOI":"10.1161\/CIRCRESAHA.108.182535"},{"key":"6289_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/pme.10.44","volume":"7","author":"VK Topkara","year":"2010","unstructured":"Topkara VK, Mann DL. Clinical applications of miRNAs in cardiac remodeling and heart failure. Personalized Med. 2010;7:531\u201348.","journal-title":"Personalized Med"},{"key":"6289_CR41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.108.183087","volume":"103","author":"V Divakaran","year":"2008","unstructured":"Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res. 2008;103:1072\u201383.","journal-title":"Circ Res"},{"key":"6289_CR42","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS ONE. 2008;3:e3148.","journal-title":"PLoS ONE"},{"key":"6289_CR43","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513\u201318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6289_CR44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/CIRCRESAHA.110.218297","volume":"106","author":"AJ Tijsen","year":"2010","unstructured":"Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010;106:1035\u20139.","journal-title":"Circ Res"},{"key":"6289_CR45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"MF Corsten","year":"2010","unstructured":"Corsten MF, Dennert R, Jochems S, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010;3:499\u2013506.","journal-title":"Circ Cardiovasc Genet"},{"key":"6289_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature. 2005;438:685\u20139.","journal-title":"Nature"},{"key":"6289_CR47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87\u201398.","journal-title":"Cell Metab"},{"key":"6289_CR48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","volume":"452","author":"J Elmen","year":"2008","unstructured":"Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature. 2008;452:896\u20139.","journal-title":"Nature"},{"key":"6289_CR49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/CIRCULATIONAHA.108.783852","volume":"119","author":"L Suckau","year":"2009","unstructured":"Suckau L, Fechner H, Chemaly E, et al. Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation. 2009;119:1241\u201352.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-011-6289-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6289-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T10:54:48Z","timestamp":1560077688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-011-6289-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,23]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["6289"],"URL":"https:\/\/doi.org\/10.1007\/s10557-011-6289-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,23]]}}}